PFE 10-Q Quarterly Report Oct. 1, 2017 | Alphaminr

PFE 10-Q Quarter ended Oct. 1, 2017

PFIZER INC
10-Qs and 10-Ks
10-K
Fiscal year ended Dec. 31, 2024
10-Q
Quarter ended Sept. 29, 2024
10-Q
Quarter ended June 30, 2024
10-Q
Quarter ended March 31, 2024
10-K
Fiscal year ended Dec. 31, 2023
10-Q
Quarter ended Oct. 1, 2023
10-Q
Quarter ended July 2, 2023
10-Q
Quarter ended April 2, 2023
10-K
Fiscal year ended Dec. 31, 2022
10-Q
Quarter ended Oct. 2, 2022
10-Q
Quarter ended July 3, 2022
10-Q
Quarter ended April 3, 2022
10-K
Fiscal year ended Dec. 31, 2021
10-Q
Quarter ended Oct. 3, 2021
10-Q
Quarter ended July 4, 2021
10-Q
Quarter ended April 4, 2021
10-K
Fiscal year ended Dec. 31, 2020
10-Q
Quarter ended Sept. 27, 2020
10-Q
Quarter ended June 28, 2020
10-Q
Quarter ended March 29, 2020
10-K
Fiscal year ended Dec. 31, 2019
10-Q
Quarter ended Sept. 29, 2019
10-Q
Quarter ended June 30, 2019
10-Q
Quarter ended March 31, 2019
10-K
Fiscal year ended Dec. 31, 2018
10-Q
Quarter ended Sept. 30, 2018
10-Q
Quarter ended July 1, 2018
10-Q
Quarter ended April 1, 2018
10-K
Fiscal year ended Dec. 31, 2017
10-Q
Quarter ended Oct. 1, 2017
10-Q
Quarter ended July 2, 2017
10-Q
Quarter ended April 2, 2017
10-K
Fiscal year ended Dec. 31, 2016
10-Q
Quarter ended Oct. 2, 2016
10-Q
Quarter ended July 3, 2016
10-Q
Quarter ended April 3, 2016
10-K
Fiscal year ended Dec. 31, 2015
10-Q
Quarter ended Sept. 27, 2015
10-Q
Quarter ended June 28, 2015
10-Q
Quarter ended March 29, 2015
10-K
Fiscal year ended Dec. 31, 2014
10-Q
Quarter ended Sept. 28, 2014
10-Q
Quarter ended June 29, 2014
10-Q
Quarter ended March 30, 2014
10-K
Fiscal year ended Dec. 31, 2013
10-Q
Quarter ended Sept. 29, 2013
10-Q
Quarter ended June 30, 2013
10-Q
Quarter ended March 31, 2013
10-K
Fiscal year ended Dec. 31, 2012
10-Q
Quarter ended Sept. 30, 2012
10-Q
Quarter ended July 1, 2012
10-Q
Quarter ended April 1, 2012
10-K
Fiscal year ended Dec. 31, 2011
10-Q
Quarter ended Oct. 2, 2011
10-Q
Quarter ended July 3, 2011
10-Q
Quarter ended April 3, 2011
10-K
Fiscal year ended Dec. 31, 2010
10-Q
Quarter ended Oct. 3, 2010
10-Q
Quarter ended July 4, 2010
10-Q
Quarter ended April 4, 2010
10-K
Fiscal year ended Dec. 31, 2009
PROXIES
DEF 14A
Filed on March 13, 2025
DEF 14A
Filed on March 14, 2024
DEF 14A
Filed on March 16, 2023
DEF 14A
Filed on March 17, 2022
DEF 14A
Filed on March 12, 2021
DEF 14A
Filed on March 13, 2020
DEF 14A
Filed on March 14, 2019
DEF 14A
Filed on March 15, 2018
DEF 14A
Filed on March 16, 2017
DEF 14A
Filed on March 15, 2016
DEF 14A
Filed on March 12, 2015
DEF 14A
Filed on March 13, 2014
DEF 14A
Filed on March 14, 2013
DEF 14A
Filed on March 15, 2012
DEF 14A
Filed on March 22, 2011
DEF 14A
Filed on March 16, 2010
TABLE OF CONTENTS
Part I - Financial InformationprintItem 1. Financial StatementsprintNote 9A. Identifiable Intangible Assets and Goodwill: Identifiable Intangible AssetsprintNote 7F. Financial Instruments: Derivative Financial Instruments and Hedging ActivitiesprintNote 5C. Tax Matters: Tax Provision/(benefit) on Other Comprehensive IncomeprintNote 1. Basis Of Presentation and Significant Accounting PoliciesprintNote 18. Segment, Geographic and Other Revenue InformationprintNote 2. Acquisitions, Sale Of Hospira Infusion Systems Net Assets, Collaborative Arrangement and Equity-method InvestmentsprintNote 3. Restructuring Charges and Other Costs Associated with Acquisitions and Cost-reduction/productivity InitiativesprintNote 4. Other (income)/deductions NetprintNote 5. Tax MattersprintNote 6. Accumulated Other Comprehensive Loss, Excluding Noncontrolling InterestsprintNote 7. Financial InstrumentsprintNote 8. InventoriesprintNote 9. Identifiable Intangible Assets and GoodwillprintNote 10. Pension and Postretirement Benefit PlansprintNote 11. Earnings Per Common Share Attributable To Common ShareholdersprintNote 12. Commitments and ContingenciesprintNote 12a 2. Legal ProceedingsprintNote 2b, Note 3printItem 2. Management S Discussion and Analysis Of Financial Condition and Results Of OperationsprintNote 9A. Identifiable Intangible Assets and Goodwill:identifiable Intangible AssetsprintNote 12a 1. Commitments and Contingencies: Legal ProceedingsprintNote 1C. Basis Of Presentation and Significant Accounting Policies: Estimates and AssumptionsprintNote 12A. Commitments and Contingencies: Legal Proceedings,printNote 1B. Adoption Of New Accounting StandardsprintNote 7E. Financial Instruments: Other Noncurrent LiabilitiesprintNote 1B. Basis Of Presentation and Significant Accounting Policies: Adoption Of New Accounting StandardsprintNote 7D. Financial Instruments: Long-term DebtprintNote 1C. Basis Of Presentation and Significant Accounting Policies:printNote 1B. Basis Of Presentation and Significant AccountingprintNote 12A. Commitments and Contingencies: Legal ProceedingsprintItem 3. Quantitative and Qualitative Disclosures About Market RiskprintItem 4. Controls and ProceduresprintPart II - Other InformationprintItem 1. Legal ProceedingsprintNote 5B. Tax Matters: Tax ContingenciesprintItem 1A. Risk FactorsprintItem 2. Unregistered Sales Of Equity Securities and Use Of ProceedsprintItem 3. Defaults Upon Senior SecuritiesprintItem 4. Mine Safety DisclosuresprintItem 5. Other InformationprintItem 6. Exhibitsprint

Exhibits

Exhibit 10.1 - Amendment No. 1 to the Pfizer Supplemental Savings Plan Exhibit 10.2 - Pfizer Inc. Global Performance Plan Exhibit 12 - Computation of Ratio of Earnings to Fixed Charges. Exhibit 15 - Accountants Acknowledgment. Exhibit 31.1 - Certification by the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. Exhibit 31.2 - Certification by the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. Exhibit 32.1 - Certification by the Chief Executive Officer Pursuant to 18 U.S.C. Section1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. Exhibit 32.2 - Certification by the Chief Financial Officer Pursuant to 18 U.S.C. Section1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.